← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 1, 2007Last known activity
Jan 12, 2017
Acquired by Vaxart on Oct 30, 2017
Timeline
1980s
- Jan 1, 1984
Aviragen Therapeutics— Founded
2010s
- Apr 23, 2012
Nabi Biopharmaceuticals— Acquired
- Jun 3, 2015
Anaconda Pharma— Acquired
- Oct 30, 2017
Vaxart— Acquired By
Drugs by trial phase (21 distinct, 41 trials)
Phase 4 (0 own, 3 via acquisition)
Phase 3 (0 own, 3 via acquisition)
Phase 2 (3 own, 8 via acquisition)
Phase 1 (2 own, 2 via acquisition)
Indications
Subsidiaries (2 direct, 3 total across the full acquisition tree)
Recent trials (28)
- NCT03024177Study directorPhase 2Jan 12, 2017
- NCT03024177Lead sponsorPhase 2Jan 12, 2017
- NCT02877264Study directorPhase 1Jun 1, 2016
- NCT02877264Lead sponsorPhase 1Jun 1, 2016
- NCT02718937Study directorPhase 2Mar 1, 2016
- NCT02718937Lead sponsorPhase 2Mar 1, 2016
- NCT02724254Study directorPhase 2Jan 1, 2016
- NCT02668367Study directorPhase 1Nov 1, 2015
- NCT02668367Lead sponsorPhase 1Nov 1, 2015
- NCT02558413Lead sponsorPhase 1Aug 1, 2015
- NCT02558413Study directorPhase 1Aug 1, 2015
- NCT02367313Lead sponsorPhase 2Feb 1, 2015
- NCT02367313Study directorPhase 2Feb 1, 2015
- NCT02204501Lead sponsorPhase 1May 1, 2014
- NCT02101866Lead sponsorPhase 1Mar 1, 2014
Details
- Founded
- Melbourne, AU Jan 1, 1984
- Last known activity
- Jan 12, 2017
Notes
--- Pre-folding founded info: 1984-06-01 Melbourne AU https://www.crunchbase.com/organization/biota-pharmaceuticals-inc ---